Upregulation of early and downregulation of terminal pathway complement genes in subcutaneous adipose tissue and adipocytes in acquired obesity

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Kaye, Sanna ^a,b   Lokki, A Inkeri ^a,c   Hanttu, Anna ^a   Nissilä, Eija ^a   Heinonen, Sini ^a   Hakkarainen, Antti ^c   Lundbom, Jesper ^c   Lundbom, Nina ^c   Saarinen, Lilli ^a   Tynninen, Olli ^a   Muniandy, Maheswary ^a   Rissanen, Aila ^a,c   Kaprio, Jaakko ^a   Meri, Seppo ^a   Pietiläinen, Kirsi H ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Haartman Hospital   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Complement system; Gene expression; Monozygotic twins; Obesity; Twin study

Indexed keywords

AZATHIOPRINE; COMPLEMENT FACTOR D; MESALAZINE; METFORMIN;

ADIPOCYTE; ADIPOQ GENE; ADIPOSE TISSUE; ARTICLE; BIOPSY; BODY FAT DISTRIBUTION; BODY MASS; CALR GENE; CENTRIFUGATION; CFH GENE; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FCN1 GENE; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; SUBCUTANEOUS FAT;

EID: 85020044799     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00545     Document Type: Article

References (48)

1. Sim RB, Tsiftsoglou SA. Proteases of the complement system. Biochem Soc Trans (2004) 32:21-7. doi:10.1042/bst0320021
2. Meri S. Self-nonself discrimination by the complement system. FEBS Lett (2016) 590:2418-34. doi:10.1002/1873-3468.12284
3. Meri S, Jarva H. Complement regulation. Vox Sang (1998) 74(Suppl 2):291-302. doi:10.1111/j.1423-0410.1998.tb05434.x
4. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 11:785-97. doi:10.1038/ni.1923
5. Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, et al. Adipsin is an adipokine that improves beta cell function in diabetes. Cell (2014) 158:41-53. doi:10.1016/j.cell.2014.06.005
6. Derosa G, Fogari E, D'Angelo A, Bianchi L, Bonaventura A, Romano D, et al. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation (2013) 36:914-20. doi:10.1007/s10753-013-9620-4
7. Peake PW, Shen Y, Walther A, Charlesworth JA. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun (2008) 367:560-5. doi:10.1016/j.bbrc.2007.12.161
8. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest (2007) 117:375-86. doi:10.1172/JCI29709
9. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8:731-7. doi:10.1038/nm724
10. Cianflone K, Maslowska M, Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol (1999) 10:31-41. doi:10.1006/scdb.1998.0272
11. Cui W, Simaan M, Laporte S, Lodge R, Cianflone K. C5a-and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol Immunol (2009) 46:3086-98. doi:10.1016/j.molimm.2009.06.007
12. Mamane Y, Chung Chan C, Lavallee G, Morin N, Xu LJ, Huang J, et al. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes (2009) 58:2006-17. doi:10.2337/db09-0323
13. Heinonen S, Saarinen L, Naukkarinen J, Rodriguez A, Fruhbeck G, Hakkarainen A, et al. Adipocyte morphology and implications for metabolic derangements in acquired obesity. Int J Obes (Lond) (2014) 38:1423-31. doi:10.1038/ijo.2014.31
14. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes (2009) 58:718-25. doi:10.2337/db08-1098
15. Zhang Y, Zitsman JL, Hou J, Fennoy I, Guo K, Feinberg J, et al. Fat cell size and adipokine expression in relation to gender, depot, and metabolic risk factors in morbidly obese adolescents. Obesity (Silver Spring) (2014) 22:691-7. doi:10.1002/oby.20528
16. Onat A, Can G, Rezvani R, Cianflone K. Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta (2011) 412:1171-9. doi:10.1016/j.cca.2011.03.005
17. Moreno-Navarrete JM, Martinez-Barricarte R, Catalan V, Sabater M, Gomez-Ambrosi J, Ortega FJ, et al. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes (2010) 59:200-9. doi:10.2337/db09-0700
18. Fujita T, Hemmi S, Kajiwara M, Yabuki M, Fuke Y, Satomura A, et al. Complement-mediated chronic inflammation is associated with diabetic microvascular complication. Diabetes Metab Res Rev (2013) 29:220-6. doi:10.1002/dmrr.2380
19. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients (2013) 5:1218-40. doi:10.3390/nu5041218
20. Hertle E, Stehouwer CD, van Greevenbroek MM. The complement system in human cardiometabolic disease. Mol Immunol (2014) 61:135-48. doi:10.1016/j.molimm.2014.06.031
21. Zhang J, Wright W, Bernlohr DA, Cushman SW, Chen X. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Am J Physiol Endocrinol Metab (2007) 292:E1433-40. doi:10.1152/ajpendo.00664.2006
22. van Greevenbroek MM, Ghosh S, van der Kallen CJ, Brouwers MC, Schalkwijk CG, Stehouwer CD. Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance. J Clin Endocrinol Metab (2012) 97:4742-52. doi:10.1210/jc.2012-2539
23. Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes (2005) 54:570-5. doi:10.2337/diabetes.54.2.570
24. Esparza-Gordillo J, Soria JM, Buil A, Almasy L, Blangero J, Fontcuberta J, et al. Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics (2004) 56:77-82. doi:10.1007/s00251-004-0660-7
25. Elks CE, den Hoed M, Zhao JH, Sharp SJ, Wareham NJ, Loos RJ, et al. Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol (2012) 3:29. doi:10.3389/fendo.2012.00029
26. Heinonen S, Buzkova J, Muniandy M, Kaksonen R, Ollikainen M, Ismail K, et al. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes (2015) 64:3135-45. doi:10.2337/db14-1937
27. Jukarainen S, Heinonen S, Ramo JT, Rinnankoski-Tuikka R, Rappou E, Tummers M, et al. Obesity is associated with low NAD(+)/SIRT pathway expression in adipose tissue of BMI-discordant monozygotic twins. J Clin Endocrinol Metab (2016) 101:275-83. doi:10.1210/jc.2015-3095
28. Heinonen S, Muniandy M, Buzkova J, Mardinoglu A, Rodriguez A, Fruhbeck G, et al. Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins. Diabetologia (2017) 60:169-81. doi:10.1007/s00125-016-4121-2
29. Kaye SM, Maranghi M, Bogl LH, Kaprio J, Hakkarainen A, Lundbom J, et al. Acquired liver fat is a key determinant of serum lipid alterations in healthy monozygotic twins. Obesity (Silver Spring) (2013) 21:1815-22. doi:10.1002/oby.20228
30. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 5:R80. doi:10.1186/gb-2004-5-10-r80
31. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res (2005) 33:e175. doi:10.1093/nar/gni179
32. Naukkarinen J, Heinonen S, Hakkarainen A, Lundbom J, Vuolteenaho K, Saarinen L, et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia (2014) 57:167-76. doi:10.1007/s00125-013-3066-y
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol (1995) 57:289-300. doi:10.2307/2346101
34. Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol (2012) 188:5682-93. doi:10.4049/jimmunol.1103760
35. Bohlson SS, O'Conner SD, Hulsebus HJ, Ho MM, Fraser DA. Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol (2014) 5:402. doi:10.3389/fimmu.2014.00402
36. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J (2008) 416:161-77. doi:10.1042/BJ20081240
37. Jalali S, Aghasi M, Yeganeh B, Mesaeli N. Calreticulin regulates insulin receptor expression and its downstream PI3 Kinase/Akt signalling pathway. Biochim Biophys Acta (2008) 1783:2344-51. doi:10.1016/j.bbamcr.2008.08.014
38. He JQ, Wiesmann C, van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol (2008) 45:4041-7. doi:10.1016/j.molimm.2008.07.011
39. Textoris J, Ivorra D, Ben Amara A, Sabatier F, Menard JP, Heckenroth H, et al. Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker. PLoS One (2013) 8:e82638. doi:10.1371/journal.pone.0082638
40. Won JC, Park CY, Oh SW, Lee ES, Youn BS, Kim MS. Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation. PLoS One (2014) 9:e103351. doi:10.1371/journal.pone.0103351
41. Park S, Mathis KW, Lee IK. The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases. Rev Endocr Metab Disord (2014) 15:45-53. doi:10.1007/s11154-013-9275-3
42. Jenne DE, Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci (1992) 17:154-9. doi:10.1016/0968-0004(92)90325-4
43. Xiao L, Yang X, Lin Y, Li S, Jiang J, Qian S, et al. Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity. Int J Obes (Lond) (2016) 40:112-20. doi:10.1038/ijo.2015.145
44. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem (2010) 285:6153-60. doi:10.1074/jbc. M109.088708
45. Schaffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab (2012) 23:194-204. doi:10.1016/j.tem.2011.12.003
46. Nestvold TK, Nielsen EW, Ludviksen JK, Fure H, Landsem A, Lappegard KT. Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4. Metab Syndr Relat Disord (2015) 13:29-35. doi:10.1089/met.2014.0099
47. Schousboe K, Willemsen G, Kyvik KO, Mortensen J, Boomsma DI, Cornes BK, et al. Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries. Twin Res (2003) 6:409-21. doi:10.1375/136905203770326411
48. Pietilainen KH, Rissanen A, Laamanen M, Lindholm AK, Markkula H, Yki-Jarvinen H, et al. Growth patterns in young adult monozygotic twin pairs discordant and concordant for obesity. Twin Res (2004) 7:421-9. doi:10.1375/1369052042335368